Related Experiment Video

Updated: Sep 28, 2025

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on: September 15, 2023

1.7K

Rare Ovarian Cancer's First Positive Trial

    Cancer Discovery
    |April 4, 2022
    PubMed

    Abstract:

    The MEK1/2 inhibitor trametinib increases progression-free survival from 7.2 months to 13 months in women with recurrent low-grade serous ovarian cancer. The drug also boosts the overall response rate from 6% to 26%.

    More Related Videos

    Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens
    05:58

    Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

    Published on: February 4, 2014

    13.6K
    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    7.4K

    Related Experiment Videos

    Last Updated: Sep 28, 2025

    Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
    05:35

    Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

    Published on: September 15, 2023

    1.7K
    Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens
    05:58

    Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

    Published on: February 4, 2014

    13.6K
    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    7.4K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.4K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.4K

    Articles linked to this work by shared authors, journal, and citation graph.

    Transmissible Cancer Discovered in Catfish.

    Cancer discovery·2026

    Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.

    Cancer discovery·2026

    Genomics of Subsequent Neoplasms in Childhood Cancer Survivors.

    Cancer discovery·2026

    A Counterintuitive Approach to Cancer Therapy.

    Cancer discovery·2026

    Rare Fusions, Real Targets: Ultraprecision Oncology in Lung Cancer.

    Cancer discovery·2026

    Lung Tumors Hack Nervous System to Drive Cachexia.

    Cancer discovery·2026

    DSCAM-AS1 Facilitates Osteosarcoma Progression via Regulating miR-211-5p/PDCD6 Axis.

    Drug development research·2026

    Common Male Genitourinary Issues: Prostate Cancer Screening and Treatment.

    FP essentials·2026

    Inter-Rater Agreement in PD-L1 (22C3) Expression Evaluation in Colon Cancer.

    Applied immunohistochemistry & molecular morphology : AIMM·2026

    Whole Genome HPV Liquid Biopsy for HPV-Associated Cancer Detection and Viral Physical State Classification.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Rule-Based Identification of a Reliable Real-World Cancer Recurrence Endpoint.

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

    Relationship of chronotype, biological rhythm characteristics and sleep quality with suicidal behavior in patients with opioid use disorder.

    Chronobiology international·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us